Table 1. Patients’ and samples’ data.
| ID | 27/07 | 86/13 | 116/14 | 118/14 | 124/15 | 141/15 | |
|---|---|---|---|---|---|---|---|
| gender | f | m | m | m | m | m | |
| age (at surgery) | 38 | 52 | 77 | 65 | 57 | 45 | |
| diagnosis | GBM WHOIV recurrent | GBM WHOIV recurrent | GBM WHOIV primary | GBM WHOIV recurrent | GBM WHOIV primary | GBM WHOIV primary | |
| molecular subtype associated transcription pattern* | classical-like | proneural-like | mesen-chymal-like | proneural-like | mesen-chymal-like | neural-like | |
| clinical background | previous diagnosis | GBM WHO IV recurrent | GBM WHO IV recurrent | GBM WHO IV primary | |||
| relapse (after first surgery) | 4 months | 2 months | 22 months | ||||
| therapy | Gliadel-wafer | STUPP | STUPP | ||||
| follow-up | therapy | Gliadel-wafer | Anti-epileptics | STUPP | alternative practitioner | STUPP | STUPP |
| relapse (after last surgery) | 4 months | 3 months | 22 months | ||||
| last visit (after last surgery) | 4 months | 8 months | 1 months | 3 months | 4 days | 22 months | |
*Based on determination of PDGFRA, NF1, EGFR and CDKN2A.